ICU Medical (ICUI) to Release Quarterly Earnings on Thursday

ICU Medical (NASDAQ:ICUI) is anticipated to announce its Q1 2025 earnings results after the market closes on Thursday, May 8th. Analysts expect the company to announce earnings of $1.23 per share and revenue of $574.15 million for the quarter.

ICU Medical Stock Performance

NASDAQ:ICUI opened at $134.32 on Wednesday. The firm has a market capitalization of $3.31 billion, a PE ratio of -29.39 and a beta of 0.87. ICU Medical has a 1 year low of $96.97 and a 1 year high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm’s fifty day simple moving average is $140.93 and its 200 day simple moving average is $155.97.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research report on Friday, May 2nd. KeyCorp cut their price target on ICU Medical from $209.00 to $191.00 and set an “overweight” rating for the company in a report on Monday, April 21st. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $162.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.